Amanda Hazel Dilmore

Amanda Hazel Dilmore

Auto-generated profile, based on publicly available information

Amanda Hazel Dilmore

Department of Pediatrics, University of California San Diego, La Jolla, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2022 in mSystems
Verified
Journal Article
Open access
CMCameron Martino
Cameron Martino
DMDaniel McDonald
Daniel McDonald
KCKalen Cantrell
Kalen Cantrell
ADAmanda Hazel Dilmore
Amanda Hazel Dilmore
YVYoshiki Vázquez-Baeza
Yoshiki Vázquez-Baeza
RKRob Knight
Rob Knight
Microbiome data analysis can be difficult because of particular data features, some unavoidable and some due to technical limitations of DNA sequencing instruments. The first step in many analyses that ultimately reveals patterns of similarities and differences among sets of samples (e.g., separating samples from sick and healthy people or samples from seawater versus soil) is calculating the difference between each pair of samples.

10 January 2025 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
ADAmanda Hazel Dilmore
Amanda Hazel Dilmore
RKRayus Kuplicki
Rayus Kuplicki
DMDaniel McDonald
Daniel McDonald
MKMegha Kumar
Megha Kumar
MEMehrbod Estaki
Mehrbod Estaki
OCon behalf of Alzheimer Gut Microbiome Project Consortium
on behalf of Alzheimer Gut Microbiome Project Consortium
This study investigated the relationship between gut microbiota and neuropsychiatric disorders (NPDs), specifically anxiety disorder (ANXD) and/or major depressive disorder (MDD), as defined by Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV or V criteria. The study also examined the influence of medication use, particularly antidepressants and/or anxiolytics, classified through the Anatomical Therapeutic Chemical (ATC) Classification System, on the gut microbiota. Both 16S rRNA gene amplicon sequencing (16S) and shallow shotgun sequencing (WGS) were performed on DNA extracted from 666 fecal samples from the Tulsa-1000 and Neurocomputational Mechanisms of Affiliation and Personality Study Center for Biomedical Research Excellence (NeuroMAP CoBRE) cohorts. The results highlight the significant influence of medication use; antidepressant use is associated with significant differences in gut microbiota beta diversity and has a larger effect size than NPD diagnosis. Next, specific microbes were associated with ANXD and MDD, highlighting their potential for non-pharmacological intervention. Finally, the study demonstrated the capability of Random Forest classifiers to predict diagnoses of NPD and medication use from microbial profiles, suggesting a promising direction for the use of gut microbiota as biomarkers for NPD. Though the effect sizes were larger in females than males, similar trends emerged for both sexes. These findings encourage future research on the gut microbiota’s role in NPD and its interactions with pharmacological treatments.

21 December 2021 in mSystems
Verified
Journal Article
Open access
ADAmanda H. Dilmore
Amanda H. Dilmore
DMDaniel McDonald
Daniel McDonald
TNTanya T. Nguyen
Tanya T. Nguyen
JAJames B. Adams
James B. Adams
RKRosa Krajmalnik-Brown
Rosa Krajmalnik-Brown
RKRob Knight
Rob Knight
GI disturbances in ASD such as severe constipation can be medically significant and often require medication. This is especially true for individuals with PTHS, suggesting that the gut microbiome may be involved in PTHS’s pathology.

20 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
GRGibraan Rahman
Gibraan Rahman
DMDaniel McDonald
Daniel McDonald
AGAntonio Gonzalez
Antonio Gonzalez
YVYoshiki Vázquez-Baeza
Yoshiki Vázquez-Baeza
LJLingjing Jiang
Lingjing Jiang
RKRob Knight
Rob Knight
Differentiating microbial communities among samples is a major objective in biomedicine. Quantifying the effect size of these differences allows researchers to understand the factors most associated with communities and to optimize the design and clinical resources required to address particular research questions. Here, we present Evident, a package for effect size calculations and power analysis on microbiome data and show that Evident scales to large datasets with numerous metadata covariates.

7 September 2023 in npj Biofilms and Microbiomes
Verified
Journal Article
Open access
PDF file
RPRoberta Poceviciute
Roberta Poceviciute
SBSaid R. Bogatyrev
Said R. Bogatyrev
ARAnna E. Romano
Anna E. Romano
ADAmanda H. Dilmore
Amanda H. Dilmore
OMOctavio Mondragón-Palomino
Octavio Mondragón-Palomino
RIRustem F. Ismagilov
Rustem F. Ismagilov
Because the small intestine (SI) epithelium lacks a thick protective mucus layer, microbes that colonize the thin SI mucosa may exert a substantial effect on the host. For example, bacterial colonization of the human SI may contribute to environmental enteropathy dysfunction (EED) in malnourished children. Thus far, potential bacterial colonization of the mucosal surface of the SI has only been documented in disease states, suggesting mucosal colonization is rare, likely requiring multiple perturbations. Furthermore, conclusive proof of bacterial colonization of the SI mucosal surface is challenging, and the three-dimensional (3D) spatial structure of mucosal colonies remains unknown. Here, we tested whether we could induce dense bacterial association with jejunum mucosa by subjecting mice to a combination of malnutrition and oral co-gavage with a bacterial cocktail (E. coliandBacteroidesspp.) known to induce EED. To visualize these events, we optimized our previously developed whole-tissue 3D imaging tools with third-generation hybridization chain reaction (HCR v3.0) probes. Only in mice that were malnourished and gavaged with the bacterial cocktail did we detect dense bacterial clusters surrounding intestinal villi suggestive of colonization. Furthermore, in these mice we detected villus loss, which may represent one possible consequence that bacterial colonization of the SI mucosa has on the host. Our results suggest that dense bacterial colonization of jejunum mucosa is possible in the presence of multiple perturbations and that whole-tissue 3D imaging tools can enable the study of these rare events.

19 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAmanda Hazel Dilmore
Amanda Hazel Dilmore
RKRayus Kuplicki
Rayus Kuplicki
DMDaniel McDonald
Daniel McDonald
MKMegha Kumar
Megha Kumar
MEMehrbod Estaki
Mehrbod Estaki
ACAlzheimer Gut Microbiome Project Consortium
Alzheimer Gut Microbiome Project Consortium
This study investigated the relationship between gut microbiota and neuropsychiatric disorders (NPDs), specifically anxiety disorder (ANXD) and/or major depressive disorder (MDD), as defined by DSM-IV or V criteria. The study also examined the influence of medication use, particularly antidepressants and/or anxiolytics, classified through the Anatomical Therapeutic Chemical (ATC) Classification System, on the gut microbiota. Both 16S rRNA gene amplicon sequencing and shallow shotgun sequencing were performed on DNA extracted from 666 fecal samples from the Tulsa-1000 and NeuroMAP CoBRE cohorts. The results highlight the significant influence of medication use; antidepressant use is associated with significant differences in gut microbiota beta diversity and has a larger effect size than NPD diagnosis. Next, specific microbes were associated with ANXD and MDD, highlighting their potential for non-pharmacological intervention. Finally, the study demonstrated the capability of Random Forest classifiers to predict diagnoses of NPD and medication use from microbial profiles, suggesting a promising direction for the use of gut microbiota as biomarkers for NPD. The findings suggest that future research on the gut microbiota’s role in NPD and its interactions with pharmacological treatments are needed.